Bispecific antibody plus white blood cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Bispecific antibody plus white blood cells, covering 2011-10-27 to 2011-10-27. Get the full timeline:
Most recent: Clinical Trial Update: Bispecific Antibody Plus White Blood Cells in Treating Patients With Recurrent or Refractory Glioblastoma Multiforme [Phase 1]